Introduction {#S1}
============

A network approach in medicine represents a shift from a reductionist approach, which considers involvement of distinct physiological components in the disease process. Although such a reductionistic approach has been fruitful in the development of therapy for Mendelian disorders (e.g., haemophilia), it has failed to uncover the true mechanism of complex disorders such as sepsis and multiple organ failure. By contrast, a network approach works on the basis that these components interact non-linearly to coordinate robust integrated functions ([@B34]).

Network analysis has now been biologically applied on multiple levels, including sub-cellular (e.g., gene expression and protein dynamics) ([@B3]; [@B43]; [@B40]), cellular (e.g., neural networks) ([@B64]; [@B27]; [@B24]) and tissue level signaling ([@B61]; [@B75]). It is now also being applied to organ system analysis at a functional level. A network approach also has non-biological medical applications, including use in the prediction of evolution of research communities ([@B85]; [@B70]) and health informatics.

Fundamental research in the emergent modern field of network physiology and network medicine has laid the foundation for understanding and quantifying global physiological behavior that results from networked interactions across systems, coordinated over a range of space and time scales. While this review by [@B37] presents an overview of the current focus and progress in the field, there is no shortage of work that continues to reinforce the link between physiological coupling, phase transitions and phenotypic network states across our complex physiological systems ([@B11]; [@B9]; [@B47]; [@B46]). Such research has yielded important findings, such as showing that the network in specific physiological states are characterized by specific topology and coupling strength between systems ([@B12]).

One of the first applications of a network approach to organ system analysis in complex disorders was proposed by [@B32], who defined the role of organs as biological oscillators that maintain orderly coupling through system-wide communication networks such as cytokines. They demonstrated the progression of the systemic inflammatory response syndrome to multiple organ dysfunction syndrome, with the impairment of interorgan connectivity being modulated by excessive inflammatory stimuli. While individual organ system dysfunction is well categorized ([@B52]), disruption of organ systems has been found to bemortality-associated.

Recently, [@B6] reported the first clinical application of network analysis to evaluate interorgan relationships between critically ill surviving and non-surviving patients with multiple organ failure. They challenged the reliability of conventional scoring methods, which sum up degrees of individual organ dysfunction to represent systemic illness pathophysiology and disease severity. Based on their network analysis, the degree of organ system disruption was associated with poor prognosis independently of conventional scoring methods. Survivors consistently yielded a higher number of edges and clusters compared to non-survivors in their organ connectivity network structures. Such a network physiology approach for the early detection of critical illnesses facilitated by big data and novel analytic and computational approaches has merit and is encouraging, even in light of limitations ([@B58]). More recently, [@B7] followed up exploring the differences in connectivity between specific organ system clusters in critically ill patients. These include the respiratory-renal-inflammatory system cluster and the cardiovascular-hepatic-coagulation system cluster. The study revealed that stability of organ clusters was preserved in survivors as long as organ systems formed an interactive network, regardless of severe dysfunction. In contrast, organ cluster instability and organ system isolation was associated with mortality.

While organ system network analysis has been applied to critical illness of an acute nature, its application to critical illness of a chronic nature has not been investigated. Liver cirrhosis represents an interesting a candidate due to its multiorgan involvement and prevalence of approximately 0.15% ([@B67]). This is characterized by portal hypertension, ascites formation, hepatorenal syndrome, hepatic encephalopathy, hyperdynamic circulation, cardiomyopathy, autonomic dysfunction and an impaired immune response ([@B26]; [@B45]; [@B82]). Cirrhosis is hence a multisystemic disease that affects the hepatic, cardiovascular, immune, renal and neurological systems ([@B67]).

Survival prediction is important in cirrhosis patients, particularly for organ transplant allocation. The Model for End-Stage Liver Disease (MELD) score has been used in recent years to this aim, and has subsequently been refined with the inclusion of serum sodium levels (MELD-Na) ([@B41]; [@B53]). This score comprizes of indices including serum bilirubin, serum creatinine, serum sodium, and coagulation factors. Recently, physiological markers (e.g., EEG and heart rate variability indices) have been shown to be independent of MELD in predicting survival ([@B57]; [@B14]). Therefore, conventional clinical scores still have room to improve in reflecting the multisystem nature of liver cirrhosis. In the present study, we aim to use a network approach to evaluate the differences in organ system connectivity between liver cirrhosis survivors and non-survivors.

Materials and Methods {#S2}
=====================

Participants and Ethics {#S2.SS1}
-----------------------

The study protocol was approved by the Hospital of Padova Ethics Committee. All participants provided written, informed consent. This study was conducted according to the Declaration of Helsinki (Hong Kong Amendment) and Good Clinical Practice (European) guidelines. The study population consists of patients with liver cirrhosis referred to the liver unit, Clinic five of the University Hospital of Padova for assessment of hepatic encephalopathy between 2009 and 2018. The exclusion criteria include patients with hepatocellular carcinoma and patients unconfirmed for hepatocellular carcinoma. Two hundred and one patients (156 males, age ± SD: 57 ± 11 years) met the inclusion/exclusion criteria. On the day of study, 26% patients were classed as Child A, 52% as B, and 22% as C. The average (±SD) MELD score was 14 ± 5 and the average MELD-Na score 15 ± 6.

Follow-Up Time and Survivors vs Non-survivors {#S2.SS2}
---------------------------------------------

Patients were classified into 3-, 6-, and 12-month follow-up groups, corresponding to a follow-up time threshold of 90, 180, and 360 days. These follow-up groups were then further classified into a survivor group and a non-survivor group.

During each follow-up, the clinical variable measurements and survivor status of patients were updated. Patients who died during the follow-up periods formed the non-survivor group. Patients who survived formed the survivor group.

Patients who had follow-up information less than a follow-up threshold were censored from analysis as their survival status is unconfirmed. For example, if a patient had a follow-up at 150 days which confirmed they were alive, but had no further update beyond that, they would be included in the 3 month follow-up group but censored from the 6 month follow-up group.

Transplantation {#S2.SS3}
---------------

During data collection of the study population, a number of patients underwent successful liver transplantation for liver failure. These patients are considered dead at the time of transplantation.

Clinical Variables {#S2.SS4}
------------------

Clinical and laboratory variables were chosen to represent individual organ or system function. These clinical and laboratory variables were derived retrospectively from a preliminary study using a Random Forest machine learning algorithm ([@B17]). Variables which did not hold any weight in contributing to the outcome of mortality in patients were excluded to ensure that our study focused on the variables that have weight in mortality prediction and are hence included in the analysis in our study. Using this approach redundant clinical variables were eliminated, narrowing down the chosen clinical variables to 13. These include C-reactive protein (CRP), serum albumin, total bilirubin, prothrombin time, international normalised ratio (INR), ammonia, hemoglobin, serum creatinine, serum sodium, ascites and hepatic encephalopathy. Hepatic encephalopathy was classified as (0) unimpaired: no clinical evidence of hepatic encephalopathy and no defining EEG or psychometric abnormalities; (1) minimal hepatic encephalopathy: no clinical evidence of hepatic encephalopathy but abnormal EEG and/or impaired psychometric performance; and (2) overt hepatic encephalopathy: clinically evident neuropsychiatric disturbances ([@B7]). An addition of the MELD-Na ([@B25]) and Child-Pugh ([@B21]; [@B62]) scores were calculated. [Table 1](#T1){ref-type="table"} indicates the list of clinical variables with their physiological interpretation.

###### 

The list of nodes (clinical variables) along with their physiological interpretation and associated major organ system(s) used in this study.

  Clinical variable                                 Physiological interpretation                                                                                                                                                          Major organ system(s)
  ------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------
  CRP (C-reactive protein)                          An acute phase protein made by the liver that is released into the blood during infection or systemic inflammation                                                                    Immune system
  Alb (serum albumin)                               The most abundant protein in blood which is synthetized by the liver. It has important function in microcirculation. It is a maker of synthetic liver function                        Hepatobiliary system and microcirculatory system
  Tot Bili (total bilirubin)                        Bilirubin is a yellow pigment that occurs in the normal catabolic pathway that breaks down haem in the body. It is excreted by the liver and is marker for excretory liver function   Hepatobiliary system and Hematologic
  PTcP (prothrombin time)                           A blood test that measures the time it takes for the blood to clot                                                                                                                    Coagulation system
  INR (International Normalized Ratio)              A blood test that measures the time it takes for the blood to clot                                                                                                                    Coagulation system
  Ammonia                                           A metabolic by-product which is eliminated after detoxification in the liver                                                                                                          Hepatobiliary system and Metabolic system
  Hb (hemoglobin)                                   A protein in the red blood cells that carries oxygen                                                                                                                                  Hematologic system
  Creatinine (serum creatinine)                     An endogenous compound that is excreted by the kidneys                                                                                                                                Renal system
  Na (serum sodium)                                 The major cation in plasma. Its concentration is tightly regulated by renal and endocrine systems                                                                                     Renal system and Endocrine system
  Ascites                                           Abnormal accumulation of fluid in the abdomen (peritoneal cavity)                                                                                                                     Microcirculatory system
  HE (hepatic encephalopathy)                       Decline in brain function that occurs as a result of severe liver disease                                                                                                             Central nervous system
  Pugh (Child-Pugh score)                           A scoring system for assessing the severity of chronic liver disease                                                                                                                  Hepatobiliary system, Coagulation system and Central nervous system
  MELD (model for end-stage liver disease-sodium)   A scoring system for assessing the severity of chronic liver disease                                                                                                                  Hepatobiliary system, Coagulation system and Renal system

Generation of Network Maps {#S2.SS5}
--------------------------

In the network maps, individual clinical variables are represented as nodes. A significant correlation between two nodes is represented by the formation of an edge.

There are many approaches using different indices to evaluate the strength of edges between clinical variables in a network map. This ranges from simple linear approaches such as the Pearson's correlation coefficient analysis to more complex non-linear approaches such as the information theory Mutual information analysis. In the present study, the approach of using the Pearson's correlation coefficient with Bonferroni's correction analysis ([@B2]) is compared against the approach of using the Mutual information analysis ([@B73]; [@B48]). An edge was formed between two clinical variable nodes if the association between two clinical variables was equal to, or greater than the determined cut-off value for the analysis index. All values that did not reach the cut-off threshold were considered zero in the adjacency matrix. For the Pearson's correlation analysis, the cut-off refers to the correlation values that have passed the Bonferroni significance threshold of 0.0038462, which is the result of an adjusted *p*-value of 0.05 taking into account the number of pairwise comparisons made. For the mutual information analysis, the optimal cut-off value to elucidate informative network connections was determined to be 0.75 after testing a range of values. The use of a lower threshold resulted in an over-saturation of network connections, yielding no interpretable information, while the use of a higher threshold resulted in a lack of network connections.

The adjacency matrices for the survivor and non-survivor groups were plotted for the follow-up times of 3, 6, and 12 months as network maps. An example is illustrated in [Figure 1](#F1){ref-type="fig"}. A force-directed graph drawing algorithm was used for network visualization. This algorithm minimizes edge crossings and facilitate clear identification of clusters in the network graph.

![**(A)** Illustration of nodes and edges **(B)** example of an adjacency matrix **(C)** the network map corresponding to the adjacency matrix in **(B)**.](fphys-11-00983-g001){#F1}

Software Development {#S2.SS6}
--------------------

All computation and analyses were carried out using MATLAB build R2018b ([@B77]). The software developed to compute organ system network analysis requires patient data input in CSV file format. Omitting headings, clinical variables occupy rows and patient data occupies columns. Where pair-matching is utilized, the software generates two equally sized datasets with samples drawn from the original dataset and pair-matched based on the chosen matching criteria. There is an element of randomization where there is more than one possible match to a given sample.

The chosen analysis index is applied and an \[*n* × *n*\] adjacency matrix is generated, where *n* represents the number of clinical variables. Fully labeled and color distinguished weighted correlation networks of survivors and non-survivors are generated as graph subplots for each follow-up timeframe. The thickness of edges reflects the weight or strength of correlation. The software has been designed to include flexibility of customization of parameters such as node labels, edge widths, node colors, node sizes, edge colors, node layout types and titles.

Furthermore, a quantitative summary table of network parameters including number of edges, degree of connectivity, betweenness and closeness is generated ([@B28]; [@B81]). An adjacency matrix of shortest paths between nodes is also included.

The written software, which code can be found in this GitHub repository ([@B74]), executes the following algorithm:

1.  Retrieve CSV format datasets for survivor and non-survivor groups. The option to pair-match datasets with randomization based on an existing column criterion can be selected at this stage (see section: Pair-matching).

2.  Execute a correlation analysis selected by user input on the datasets.

3.  Output a weighted correlation adjacency matrix.

4.  Generate a network map based on this adjacency matrix.

5.  Calculate network quantification parameters.

Pair-Matching {#S2.SS7}
-------------

During follow-up timeframes, the number of patients in the survivor and non-survivor groups continually change. As a result, the comparisons made between survivor and non-survivor group datasets drew unequal sample sizes, which could lead to a clearer observed effect in the larger sample size group. Furthermore, there may have been a difference in the severity levels of liver disease between survivor and non-survivor groups resulting in the observed effects. Pair-matching was hence implemented as a further step after initial general analysis to control for sample size and MELD-Na score ([@B54]). The option to pair-match can be included in step 1 of the software algorithm, using the additional pair-matching algorithm outlined in [Supplementary Appendix A](#TS1){ref-type="supplementary-material"}.

After pair-matching, the original algorithm detailed in the previous software development section will continue executing step 2 to 5. With the removal of the pair-matched criteria column, the number of clinical variables becomes 12. To prevent confusion, non-pair-matched analyses will be termed general analysis.

Correlation Analysis {#S2.SS8}
--------------------

Pearson's correlation is a good measure to evaluate linear correlation between two variables, given the normal distribution of underlying data ([@B60]). This represents a simplified approach in getting a preliminary, general overview of interorgan relationship in patients. However, it is widely known that biological signaling and regulatory networks are dynamic and complex ([@B34]; [@B39]; [@B15]). Information theory measures account for the quantity of biological information transmitted independently of network complexity, and are hence robust and sensitive to non-linear relationships and better suited for organ system network analysis ([@B73]; [@B63]).

Mutual information is one measure that calculates the reduction in the uncertainty of information transmitted between two variables, widely used in network reconstruction and reverse engineering ([@B13]; [@B87]; [@B36]; [@B59]). It is defined as the difference between the joint entropy of X and Y and the joint entropy under the assumption of independence of X and Y, with the formula ([@B48]):
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The higher the mutual information between two variables, the more dependent the two variables are to each other. The mutual information analysis was computed using an external script ([@B56]). The cut-off for this analysis index was *I*(*X*;*Y*) ≤ 0.75.

Network Analysis {#S2.SS9}
----------------

The differences in organ system interaction between survivor and non-survivor groups was evaluated quantitatively and qualitatively for the follow-up timeframes of 3, 6, and 12 months using the Bonferroni corrected Pearson's correlation and mutual information analysis indices.

Quantitatively, organ system interaction was evaluated using:

1.  Total number of edges. This is the conventional method of comparison for differences in network structure ([@B78]; [@B65]).

2.  Average degree of connectivity. A node's degree of connectivity is the total number of edges connected to the node ([@B28]; [@B81]).

3.  Average closeness. A node's closeness measure is the inverse sum of distances from the node to all other nodes in the network graph and is otherwise a measure of centrality ([@B28]; [@B81]).

Qualitatively, we attempt to explain the clinical significance of notable organ system interactions and changes observed in the network maps of patients.

Results {#S3}
=======

Patient Groups {#S3.SS1}
--------------

The number of patients in the survivor and non-survivor groups over a follow-up timeframe of 3, 6, and 12 months is outlined in [Table 2](#T2){ref-type="table"} for general, MELD-Na pair-matched Bonferroni corrected Pearson's correlation analysis and for MELD-Na pair-matched mutual information analysis.

###### 

Number of patients for (A) general analysis, (B) pair-matched correlation analysis, and (C) pair-matched mutual information analysis.

  Follow-up time                                                             Survivors   Non-survivors   Total
  -------------------------------------------------------------------------- ----------- --------------- -------
  **(A) General analysis**                                                                               
  3 months                                                                   187         14              201
  6 months                                                                   141         21              162
  12 months                                                                  75          31              106
  **(B) Pair-matched Bonferroni corrected Pearson's correlation analysis**                               
  3 months                                                                   11          11              22
  6 months                                                                   13          13              26
  12 months                                                                  17          17              34
  **(C) Pair-matched mutual information analysis**                                                       
  3 months                                                                   14          14              28
  6 months                                                                   13          13              26
  12 months                                                                  17          17              34

Network Structure {#S3.SS2}
-----------------

[Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} refers to the network structure of the 3- and 6-month Bonferroni corrected Pearson's correlation analysis. There is a clear central cluster in survivors consistently throughout both months, with a lack of any substantial clusters in non-survivors.

![3-month Bonferroni corrected Pearson's correlation analysis network map.](fphys-11-00983-g002){#F2}

![6-month Bonferroni corrected Pearson's correlation analysis network map.](fphys-11-00983-g003){#F3}

[Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} refers to the network structure of the 3- and 6-month mutual information analysis. In survivors, there is a central cluster of high interconnectivity in the 3 month network, but this cluster fails to materialize in the 6 month network. Conversely in non-survivors, there are no substantial clusters that are detected.

![3-month mutual information analysis network map.](fphys-11-00983-g004){#F4}

![6-month mutual information analysis network map.](fphys-11-00983-g005){#F5}

[Figure 6](#F6){ref-type="fig"} refers to the network structure of the 6-month pair-matched Bonferroni corrected Pearson's correlation analysis. In survivors, there is a substantial central cluster with edges branching out of the central node CRP. Conversely in non-survivors, there are no substantial clusters that are detected.

![6-month pair-matched Bonferroni corrected Pearson's correlation analysis network map.](fphys-11-00983-g006){#F6}

[Figure 7](#F7){ref-type="fig"} refers to the network structure of the 3-month pair-matched mutual information analysis. There is a central cluster of high interconnectivity in survivors compared to a lack of network in non-survivors.

![3-month pair-matched mutual information analysis network map.](fphys-11-00983-g007){#F7}

Overall, the network structure in survivor groups show consistent central clustering with high connectivity, in line with the overall higher number of edges compared to the non-survivor groups. Quantification of the networks are covered in the next section. The network structure for all follow-up times (3-, 6-, and 12-month) can be found in [Supplementary Appendix B](#TS2){ref-type="supplementary-material"}.

Network Analysis Quantification {#S3.SS3}
-------------------------------

The network parameters measured for each network map in the general analysis is summarized in [Table 3](#T3){ref-type="table"} for Bonferroni corrected Pearson's correlation analysis, mutual information analysis, and the respective pair-matched analysis.

###### 

Network parameters for **(A)** correlation analysis, **(B)** mutual information analysis, **(C)** pair-matched correlation analysis, and **(D)** pair-matched mutual information analysis.

                                                                             No. of edges    Average degree of connectivity   Average closeness   *t*-test *p*-value (degree)   *t*-test *p*-value (closeness)   
  -------------------------------------------------------------------------- --------------- -------------------------------- ------------------- ----------------------------- -------------------------------- ----------
  **(A) Bonferroni corrected Pearson's correlation analysis**                                                                                                                                                    
  3 months                                                                   Survivors       26                               4.00                0.0383                        1.10E-04                         1.44E-06
                                                                             Non-survivors   1                                0.15                0.0011                                                         
  6 months                                                                   Survivors       20                               3.08                0.0293                        1.28E-03                         8.26E-05
                                                                             Non-survivors   2                                0.31                0.0021                                                         
  12 months                                                                  Survivors       12                               1.85                0.0193                        3.26E-02                         8.46E-03
                                                                             Non-survivors   5                                0.77                0.0070                                                         
  **(B) Mutual Information analysis**                                                                                                                                                                            
  3 months                                                                   Survivors       16                               2.46                0.0182                        1.53E-03                         1.45E-03
                                                                             Non-survivors   0                                0.00                0.0000                                                         
  6 months                                                                   Survivors       1                                0.15                0.0011                        1.86E-01                         1.86E-01
                                                                             Non-survivors   2                                0.31                0.0021                                                         
  12 months                                                                  Survivors       0                                0.00                0.0000                                                         
                                                                             Non-survivors   0                                0.00                0.0000                                                         
  **(C) Pair-matched Bonferroni corrected Pearson's correlation analysis**                                                                                                                                       
  3 months                                                                   Survivors       0                                0.00                0.0000                                                         
                                                                             Non-survivors   0                                0.00                0.0000                                                         
  6 months                                                                   Survivors       14                               2.33                0.0494                        9.38E-03                         1.73E-09
                                                                             Non-survivors   2                                0.33                0.0028                                                         
  12 months                                                                  Survivors       3                                0.50                0.0041                        0.5                              0.5
                                                                             Non-survivors   3                                0.50                0.0041                                                         
  **(D) Pair-matched mutual information analysis**                                                                                                                                                               
  3 months                                                                   Survivors       30                               5.00                0.0413                        2.22E-04                         2.81E-04
                                                                             Non-survivors   5                                0.83                0.0079                                                         
  6 months                                                                   Survivors       15                               2.50                0.0321                        3.39E-04                         1.93E-06
                                                                             Non-survivors   6                                1.00                0.0112                                                         
  12 months                                                                  Survivors       6                                1.00                0.0106                        1.55E-02                         7.75E-03
                                                                             Non-survivors   2                                0.33                0.0028                                                         

Discussion {#S4}
==========

The novel approach of organ system network analysis seeks to elucidate the complex mechanisms underlying life-threatening diseases of multisystem nature, in recognition that current linear clinical scores can be improved upon in assessing and reflecting ([@B10]; [@B35]). By choosing clinical variables to represent organ systems, our study evaluated the differences in organ system connectivity between survivors and non-survivors of a group of 201 liver cirrhosis patients.

Our results demonstrate that organ system interaction was overall significantly higher in survivors compared to non-survivors, quantified by the total number of edges, average degree of connectivity and average closeness ([Table 3](#T3){ref-type="table"}). These findings support the hypothesis that decreased organ system interaction is associated with poor prognosis in chronic liver failure. Our findings also continue to support previous studies suggesting that systemic dysfunction in acute life-threatening pathophysiology with multisystem involvement is attributed to a loss of homeostatic interorgan connectivity ([@B19]; [@B22]), most notably in the recent studies published by [@B6], [@B7]. Although our study explores multisystem disease of a chronic nature, the characteristics associated with poor prognosis in non-survivors remain similar, namely the breakdown of organ system connectivity, loss of homeostatic stability and isolation of individual organ system clusters. The results of this study validate the use of a network approach in previously unexplored multisystem disease of a chronic nature and continues to highlight the importance of organ system network analysis in evaluating systemic stability of patients to improve prognostic outcome. However, it must be duly noted that this conclusion only applies to patients who have followed up and thus have a confirmed outcome at the end of the study. Patients with censored data (i.e., unknown outcome) may harbor bias within the network outcome by having a specific phenotype that results in their leaving of the study.

Current survival prediction and analysis scores such as the MELD-Na and Child-Pugh score for liver cirrhosis patients and their room for improvement in accountability of the complex mechanisms of multisystem disease encourages the consideration and investigation of alternate approaches such as the network approach. This is especially important as these scores form the basis of clinically important decisions such as the allocation of organ transplantation priority. Indeed, there has been a gradual shift toward a network approach where the original MELD score's failure to account for specific pathophysiology and their effects on mortality risk prompted the transformation of the MELD score into the MELD-Na score ([@B84]; [@B53]). Still, it is recognized that the extension of this clinical score to include renal biomarkers still leaves room to account for the systemic pathophysiology of liver cirrhosis. Some studies have suggested the addition of further predictive components such as in the proposal of the MELD-Plus score ([@B42]), while other studies have identified physiomarkers independent to the MELD score in mortality prediction. [@B57] has shown that the addition of an EEG-based hepatic encephalopathy index to MELD improves prognostic accuracy, while [@B14] has defined two heart rate variability indices that predict mortality in cirrhosis patients independently to MELD. The liver remains the primary site of initial pathophysiology development in cirrhosis, and though it is important to include specific liver biomarkers in survivor analysis, the progression of cirrhosis and its downstream effects means that inclusion of involved organ system biomarkers is paramount to reflecting the true complexity of liver cirrhosis.

The use of the Pearson's correlation and mutual information analysis represent two approaches to defining the association strength between variables. Pearson's correlation performs well under the assumption of linearity, but is widely used as the general correlation analysis index to elucidate preliminary information about a new dataset ([@B60]). In this study, such an approach is useful for achieving a general overview of the basic links within the network. Mutual information, as previously specified, accounts for the quantity of biological information transmitted independent of network complexity, and is sensitive to non-linear relationships ([@B73]; [@B63]). As biological networks operate in a dynamic and non-linear manner, the mutual information analysis presents a more robust measure in discerning and evaluating the true network structure of organ systems. In present study we observed that although both correlation and mutual information analyses exhibited higher network connectivity in survivors, some connections could only be detected by mutual information analysis. For example, hemoglobin level does not seem to be an important part of the correlation network in patents with cirrhosis while mutual information analysis indicates that hemoglobin is a hub in the survivor group and shares mutual dependence with other clinical variables such as serum albumin, creatinine, sodium and markers of blood coagulation. This finding may shed lights on possible adaptive mechanisms in cirrhosis which cannot be easily discovered using simple linear analyses such as Pearson's correlation.

It is a possibility that the differences in networks between survivors or non-survivors could have been attributed to differences in the degree of liver cirrhosis severity across both groups, such that non-survivors might have an overall higher degree of disease severity. To correct for this, we carried out an analysis with pair-matching patients for MELD-Na scores. In the outcome of network graphs, there is a clear difference in the network structure between non-pair-matched and pair-matched analyses. Furthermore, the structural evolution of the networks over time also differs between non-pair-matched and pair-matched analyses. With regards to the Bonferroni corrected Pearson's correlation analysis, the 6-month network structure of the pair-matched data ([Figure 6](#F6){ref-type="fig"}) yields the most information as opposed to the 3 month network structure of the non-pair-matched data ([Figure 3](#F3){ref-type="fig"}). From this, we can conclude that the degree of severity of disease is not the only driver of prognosis as the networks evolve.

We also sought to qualitatively analyse the clinical significance behind notable interactions seen on the network maps of patients. Such clinical significance can be expressed in the scope of validated literature of known pathophysiology. However, it is important to highlight that some of the interactions between clinical variables are obvious and expected, such as the \[MELD-Na -- total bilirubin\] link and the \[INR -- prothrombin time\] link, as these variables are closely related with a degree of dependency.

Of clinical significance are the difference in interactions of CRP in the network maps of survivors and non-survivors and the role of systemic inflammation. The survivor group maintains integration of CRP within the central cluster, whereas this interaction is lost or heavily isolated in the non-survivor group ([Figures 6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}). Conclusively, survivors maintain a link to the inflammatory and immune system, while non-survivors experience uncoupling of systemic inflammation from organ systems. CRP is an acute inflammatory protein synthesized primarily in the liver and is a key component in systemic inflammation ([@B72]). Systemic inflammation is associated with disease progression in liver cirrhosis and patient mortality, accompanying the transition from compensated to decompensated cirrhosis, otherwise known as the systemic inflammatory response syndrome (SIRS) ([@B31]; [@B49]). SIRS is triggered by systemic and life-threatening insults to the body ([@B8]).

Like many other life-threatening conditions such as sepsis, liver cirrhosis patients typically observe two phases associated with systemic inflammation. The first phase involves an increase in circulating cytokines, notably IL-6 and TNF-receptor expression ([@B80]; [@B44]), which result in increased production of acute phase proteins such as CRP ([@B55]; [@B69]). This increase in circulating cytokines is largely attributed to hepatocyte death and bacterial translocation from increased intestinal permeability as a consequence of portal hypertension ([@B1]; [@B4]; [@B18]; [@B38]). SIRS is hence characteristically observed in decompensated cirrhosis patients regardless of the presence of bacterial infection and is further associated with complications including hepatic encephalopathy and variceal bleeding ([@B68]; [@B76]; [@B20]). SIRS acts in the capacity of a compensatory mechanism in maintaining systemic stability in the presence of other dysfunctional systems against life threatening illness ([@B29]; [@B7]).

The second phase occurs in the form of immune exhaustion, and in the context of liver cirrhosis is known as cirrhosis-associated immune dysfunction (CAID) syndrome ([@B1]). CAID syndrome manifests through excessive activation of the inflammatory and immune system and loss of liver immune surveillance, resulting in non-responsiveness to immune challenges, endotoxin tolerance and immunodeficiency ([@B79]; [@B30]; [@B71]). Given the homeostatic role of the liver in systemic immunity, progressive loss of liver function can consequently lead to failure in regulating the inflammatory response ([@B23]). Examples of such mechanism involve the breakdown of gp130-STAT3 signaling in hepatocytes and production failure of acute phase proteins. These components control the inflammatory response through mediation of autoregulatory myeloid-derived suppressor cells, an innate immune response in sepsis ([@B83]; [@B66]). The onset of a bacterial infection can be encouraged by the immunodeficient environment associated with CAID syndrome, or conversely it can push the onset of CAID syndrome. Regardless, the additional presence of bacterial infection increases the probability of mortality four-fold ([@B5]) and likely represents the transition point of a patient into an uncontrolled septic state. This is significant as sepsis is responsible for 50% of deaths in cirrhosis patients ([@B83]). This transition point also likely reflects the loss of integration of the axis of inflammation with organ systems in non-survivors as a prognostic determinant, brought about by CAID syndrome in conjunction to bacterial infection. Consequently, we should expect to see the presence of peritonitis or infection in non-survivors.

The presence of highly interlinked central clusters observed in the network maps of survivors reflects successful homeostatic organ system connectivity, yet this is unlikely to be seen in normal, healthy people as increased organ system connectivity has been established as a compensatory mechanism to maintain homeostatic stability in preventing mortality during life-threatening illness ([@B29]; [@B7]). In fact, the network structures observed may indeed be a reflection of overcompensation, the same way the fight or flight reaction is all or nothing.

A correlation analysis is appropriate for generating the network map of a group of patients, given that multiple samples are available for each pair of variables being analyzed. However, this approach does not work with only a single patient, a shortcoming of such network analysis for feasible application in medicine. To make the network approach clinically viable, there must be a method to analyze the network of a single patient. This is made possible with a recently introduced network type, termed a parenclitic network, which makes it possible to represent a collection of isolated and heterogenous scalar values as a network ([@B86]). The basis upon which this works is by calculating the deviation between the data of a single patient with the pre-constructed reference model to weight the link between corresponding nodes. This mathematical framework involving high level analysis is suitable regardless of relationship type or dataset, as long as features are numerical. With this approach, the network map of a single patient can be generated and analyzed mathematically, and with expert domain knowledge input, presents a viable method in evaluating multisystem disease.

Further models using a network approach should include more physiological data, such as heart rate variability and temperature variability indices. Reduced heart rate variability and body temperature variability are known to be inversely associated with increased mortality in cirrhosis patients, where their prognostic value is independent of MELD or Pugh scores ([@B50]; [@B14]; [@B16]). In a subset of patients investigated, the uncoupling of the autonomic nervous system and cardiovascular system was found to be associated with mortality in liver cirrhosis patients. Clinically, excessive inflammation during cirrhosis progression is known to facilitate cytokine-induced autonomic neuropathy and the uncoupling of the cardiac pacemaker regulation ([@B33]). While such a physiomarker adds immense clinical value to the model, further exploration is required to determine the optimal subset and number of clinical variables for organ system representation and network analysis. A wide range of feature selection methods exist that may be helpful in arriving at the optimal subset of clinical variables ([@B51]) and should be further investigated. Future studies will benefit from including larger number of patients from different hospitals. The low number of patients used to construct the non-survivor networks presents as a limitation in our study. Our data cannot be generalized to all cirrhotic patients as our cohort of patient data comes from a single hospital and our conclusions can only apply to patients who have followed up throughout the length of the study.

Conclusion {#S5}
==========

This is the first study to apply an organ system network analysis approach to a multisystem disease of chronic nature, providing quantitative and qualitative evidence of the role of systemic stability in patient outcome. Such an evaluation method of organ system interactions has high potential in clinical application for improving patient outcomes with proper implementation, given the room to improve within our current clinical score methods for decision making in the accountability of the complex pathophysiology of multisystem disease.
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